269 related articles for article (PubMed ID: 31897763)
1. Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown.
Gurewich V
Cardiovasc Drugs Ther; 2019 Dec; 33(6):749-753. PubMed ID: 31897763
[TBL] [Abstract][Full Text] [Related]
2. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
3. In silico study of combination thrombolytic therapy with alteplase and mutant pro-urokinase for fibrinolysis in ischemic stroke.
Yang Y; Gu B; Xu XY
Comput Biol Med; 2024 Mar; 171():108141. PubMed ID: 38367449
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.
Clase CM; Crowther MA; Ingram AJ; Cinà CS
J Thromb Thrombolysis; 2001 Apr; 11(2):127-36. PubMed ID: 11406727
[TBL] [Abstract][Full Text] [Related]
5. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.
Gurewich V
J Am Coll Cardiol; 2016 Nov; 68(19):2099-2106. PubMed ID: 27810050
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis: A Critical First-Line Therapy with an Unfulfilled Potential.
Gurewich V
Am J Med; 2016 Jun; 129(6):573-5. PubMed ID: 26714208
[TBL] [Abstract][Full Text] [Related]
8. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Maksimenko AV; Tischenko EG
J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
López-Sendón JL
Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
[TBL] [Abstract][Full Text] [Related]
10. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
[TBL] [Abstract][Full Text] [Related]
11. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
12. Appraisal of various thrombolytic agents in the treatment of acute myocardial infarction.
Sherry S
Am J Med; 1987 Aug; 83(2A):31-46. PubMed ID: 3115099
[TBL] [Abstract][Full Text] [Related]
13. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
Peuhkurinen K; Risteli L; Jounela A; Risteli J
Am Heart J; 1996 Jan; 131(1):7-13. PubMed ID: 8554022
[TBL] [Abstract][Full Text] [Related]
14. Combinations of thrombolytic agents in acute myocardial infarction.
Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular pharmacology (XIII). The efficacy of different thrombolytic drugs in the treatment of acute myocardial infarct].
López-Sendón J; López de Sá E; Bobadilla JF; Rubio R; Bermejo J; Delcán JL
Rev Esp Cardiol; 1995 Jun; 48(6):407-39. PubMed ID: 9324694
[TBL] [Abstract][Full Text] [Related]
16. Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.
Pannell R; Li S; Gurewich V
J Thromb Thrombolysis; 2017 Aug; 44(2):210-215. PubMed ID: 28600623
[TBL] [Abstract][Full Text] [Related]
17. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
18. Intravenous fibrinolytic therapy of acute myocardial infarction: new perspectives from plasminogen activators?
Kasper W; Meinertz T; Just H
Klin Wochenschr; 1986 Apr; 64(7):301-6. PubMed ID: 3086619
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Rao AK; Pratt C; Berke A; Jaffe A; Ockene I; Schreiber TL; Bell WR; Knatterud G; Robertson TL; Terrin ML
J Am Coll Cardiol; 1988 Jan; 11(1):1-11. PubMed ID: 3121710
[TBL] [Abstract][Full Text] [Related]
20. Fibrin-specific thrombolytic agents.
Collen D
Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
